NASDAQ · Specialty Chemicals · USD
Linde plc (LIN) Stock Analysis
Linde plc (LIN) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
LIN Key Statistics
As of Sep 4, 2026Trading
- Open
- $479.25
- Previous Close
- $482.19
- Day's Range
- 476.48–482.96
- 52-Week Range
- 387.78–548.20
- Volume
- 2.27M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.73
Valuation
- Market Cap
- $220.15B
- P/E Ratio
- 30.85
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 24.42
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.87
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 6.21
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 15.48
Financials (FY)
- Revenue (FY)
- $33.99B+2.97%
- Net Income (FY)
- $6.90B+5.07%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 20.43%
- Shares Outstanding
- 460.98M
- 1-Year Return
- +2.13%
Dividend and dates
- Dividend
- $6.40+1.33%
- Ex-Dividend Date
- September 3, 2026
- Earnings Date
- October 30, 2026
- Avg Volume
- 2.21M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
LIN Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +12.73% |
| 2025 | +3.22% |
| 2024 | +3.18% |
| 2023 | +27.66% |
| 2022 | −4.39% |
| 2021 | +33.39% |
| 2020 | +25.88% |
| 2019 | +39.04% |
| 2018 | +3.01% |
| 2017 | +35.14% |
| 2016 (partial year) | +1.58% |
As of September 4, 2026.
LIN Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $33.99B | $6.90B | 20.3% |
| 2024 | $33.01B | $6.57B | 19.9% |
| 2023 | $32.85B | $6.20B | 18.9% |
| 2022 | $33.36B | $4.15B | 12.4% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $33.99B | $16.60B | $9.25B | $6.90B | 20.3% |
| 2024 | $33.01B | $15.86B | $8.60B | $6.57B | 19.9% |
| 2023 | $32.85B | $15.36B | $8.11B | $6.20B | 18.9% |
| 2022 | $33.36B | $13.91B | $6.46B | $4.15B | 12.4% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
LIN Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $4.80 | 3 | — |
| 2025 | $6.00 | 4 | +7.9% |
| 2024 | $5.56 | 4 | +9.0% |
| 2023 | $5.10 | 4 | +9.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $4.80 | 3 | — |
| 2025 | $6.00 | 4 | +7.9% |
| 2024 | $5.56 | 4 | +9.0% |
| 2023 | $5.10 | 4 | +9.0% |
| 2022 | $4.68 | 4 | +10.4% |
| 2021 | $4.24 | 4 | +10.1% |
| 2020 | $3.85 | 4 | +10.1% |
| 2019 | $3.50 | 4 | +6.1% |
| 2018 | $3.30 | 4 | +4.7% |
| 2017 | $3.15 | 4 | +110.1% |
| 2016 | $1.50 | 2 | — |
Most recent payment: $1.60 per share, ex-dividend September 3, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
LIN Valuation vs Specialty Chemicals Median
Median of 71 stocks| Metric | LIN | Specialty Chemicals median | vs median |
|---|---|---|---|
| P/E | 30.85 | 28.71 | 7% above |
| P/S ratio | 6.21 | 1.68 | 3.7x the median |
| Profit margin | 20.43% | 0.08% | 20.4 pts above |
Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Is Linde Stock Underperforming the Dow?
YahooIf You Invested $100 In Linde Stock 10 Years Ago, You Would Have This Much Today
BenzingaIs Lindian Resources (ASX:LIN) Expensive As Kangankunde Stays On Track For Q4 2026?
YahooEurope Liquid Hydrogen Market Report 2026–2035: Evaluating $13.1 Billion Forecast, Cryogenic Distribution, and Strategies of Linde, Air Liquide, Chart Industries, and Air Products
YahooLinde Stock: Is Wall Street Bullish or Bearish?
YahooHere’s How Much You Would Have Made Owning Linde Stock In The Last 10 Years
Benzinga
All 20 articles ↓Show fewer ↑
BMO Capital Maintains Outperform on Linde, Lowers Price Target to $546
BenzingaJim Cramer Called Linde plc (NASDAQ:LIN)’s Share Price Movement “Stupid”
YahooLinde (LIN) vs. Air Products (APD): Racing for the Chip Boom
YahooLinde Stock Barely Moved While Its Order Book Hit A Record
YahooCitigroup Maintains Buy on Linde, Lowers Price Target to $580
BenzingaLinde: My 'Not Cheap' Thesis Has Been True Since 2023
SeekingAlphaRBC Capital Maintains Outperform on Linde, Lowers Price Target to $553
BenzingaBernstein Maintains Outperform on Linde, Raises Price Target to $564
BenzingaLinde (LIN) Posted Record Q2 Results, Is The 12% Upside Still Real?
YahooLinde PLC (LIN) (Q2 2026) Earnings Call Highlights: Record Sales and EPS Amid Margin Pressures
YahooLinde plc Q2 2026 Earnings Call Summary
YahooLinde Q2 Earnings Call Highlights
YahooLIN Q2 Earnings & Revenues Beat Estimates on Volume & Pricing Growth
YahooLinde plc (LIN) Q2 2026 Earnings Call Transcript
SeekingAlpha
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Specialty Chemicals Stocks
The Sherwin-Williams Company
$81.01B
ECLEcolab Inc.
$78.29B
APDAir Products and Chemicals, Inc.
$67.09B
PPGPPG Industries, Inc.
$25.02B
IFFInternational Flavors & Fragrances Inc.
$22.03B
SQMSociedad Química y Minera de Chile S.A.
$21.83B
Popular Basic Materials Stocks
BHP Group Limited
$229.80B
RIORio Tinto Group
$167.95B
SCCOSouthern Copper Corporation
$167.82B
NEMNewmont Corporation
$134.97B
FCXFreeport-McMoRan Inc.
$104.44B












